Switch from analogue to human insulin reduces part D coverage gap risk for Medicare beneficiaries

Medicare beneficiaries with type 2 diabetes switched from analogue to human insulin were less likely to reach the spending limit for their Part D drug plan — commonly known as the “donut hole” — with no changes in hospitalization rates for hypoglycemia or hyperglycemia and only a slightly increased mean HbA1c, according to a speaker here.

View Article